ホーム › 転移性癌 › アリゾナ州 › Scottsdale
Scottsdale、AZにおける転移性癌の臨床試験
Scottsdaleとその周辺地域（約30マイル以内）の拠点で、転移性癌に関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
被験者募集中
- Mayo Clinic in Arizona, Scottsdale
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
被験者募集中第2相
- Mayo Clinic in Arizona, Scottsdale
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第3相
- Mayo Clinic, Scottsdale
- Ironwood Cancer & Research Centers, Scottsdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- Ironwood Cancer & Research Centers, Scottsdale
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
被験者募集中第1/2相
- Mayo Clinic Arizona, Scottsdale
A Study of KK2269 in Adult Participants With Solid Tumors
被験者募集中第1相
- Mayo Clinic Arizona, Scottsdale
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
被験者募集中第2相
- Research Site, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Honor Health, Scottsdale
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Mayo Clinic (Arizona), Scottsdale
A Study of PYX-201 in Advanced Solid Tumors
被験者募集中第1相
- HonorHealth Research Institute, Scottsdale
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Research Site, Scottsdale
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
被験者募集中第2/3相
- HonorHealth Research Insisute, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- HonorHealth Research Institute, Scottsdale
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
被験者募集中第1相
- Honor Health Research Institute, Scottsdale
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
被験者募集中第1/2相
- Honor Health Resarch Institute, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
被験者募集中第1/2相
- Mayo Clinic in Arizona, Scottsdale
他の都市における転移性癌の試験
- Houston, TX104件の研究
- New York City, NY93件の研究
- Nashville, TN70件の研究
- Boston, MA63件の研究
- Los Angeles, CA57件の研究
- St. Louis, MO54件の研究
- Arlington, VA53件の研究
- Philadelphia, PA46件の研究
- Chicago, IL45件の研究
- San Antonio, TX44件の研究
- Washington, DC43件の研究
- Dallas, TX42件の研究
Scottsdaleにおける他の研究
- 乳がん18件の研究
- がん（全種類）18件の研究
- 前立腺がん17件の研究
- 大腸癌16件の研究
- 非小細胞肺癌15件の研究
- 膵臓がん13件の研究
- 悪性黒色腫10件の研究
- 潰瘍性大腸炎8件の研究
- 肺がん8件の研究
- 肝臓がん（肝細胞がん）7件の研究
- アルツハイマー病7件の研究
- トリプルネガティブ乳がん7件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。